London Daily

Focus on the big picture.
Sunday, Jun 01, 2025

Technology can help the NHS, says AstraZeneca boss

Technology can help the NHS, says AstraZeneca boss

The chairman of Covid vaccine giant AstraZeneca has said that investment in technology can help the NHS cut costs.

Leif Johansson said more spending on areas such as artificial intelligence and screening could prevent illness and stop people going to hospital.

The NHS is under severe pressure, with A&E waits at record levels and strike action exacerbating ambulance delays.

Mr Johansson said about 97% of healthcare costs come from "when people present at the hospital".

He said only the remaining 3% is made up of spending on vaccination, early detection or screening.

Mr Johansson told the BBC at the World Economic Forum in Davos: "If we can get into an investment mode in health for screening or prevention or early diagnostics on health and see that as an investment to reduce the cost of sickness then I think we have a much better model over time that would serve us well."

Commenting on the UK, he said: "All countries have different systems and the NHS is one which we have learned to live with and I think the Brits, in general, are quite appreciative about it."

He said he was not talking about "breaking any healthcare systems down". Rather, he said, "we should embrace technology and science".

Mr Johansson said that artificial intelligence, or AI, could be used to diagnose lung cancer through X-rays by "just running them through software". Or technology could be used to screen diabetes or cardiovascular diseases.

"All of that can be done within the institution of the NHS and would still have a very beneficial impact," he said.

The NHS is facing more industrial action on Monday when ambulance workers in some parts of England and Wales, who are members of the Unite union, go out on strike in a dispute over pay.

There are further strikes planned by ambulance workers and nurses later this month and in February.


Following the UK's exit from the European Union, Mr Johansson had expressed concern about whether AstraZeneca would continue investing in the country.

But he now says that the UK has the opportunity to innovate in technology for the healthcare sector outside of European regulations.

"The UK already has a very, very good life science sector academically but also industrially with a couple of very large players, ourselves included.

"Anything that we can do in the UK would be beneficial for the country on a broader aspect than only using it in the UK."

Mr Johansson will step down as non-executive chairman of AstraZeneca in April.

He will be replaced by Michel Demaré, currently a non-executive director at the pharmaceutical company who holds similar roles at Vodafone among others.


Newsletter

Related Articles

0:00
0:00
Close
Hegseth Warns of Potential Chinese Military Action Against Taiwan
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Jamie Dimon Warns U.S. Bond Market Faces Pressure from Rising Debt
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Taylor Swift Gains Ownership of Her First Six Albums
Bangkok Ranked World's Top City for Remote Work in 2025
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
Italy Faces Population Decline Amid Youth Emigration
U.S. Goods Imports Plunge Nearly 20% Amid Tariff Disruptions
OpenAI Faces Competition from Cheaper AI Rivals
Foreign Tax Provision in U.S. Budget Bill Alarms Investors
Trump Accuses China of Violating Trade Agreement
Gerry Adams Wins Libel Case Against BBC
Russia Accuses Serbia of Supplying Arms to Ukraine
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
Chinese Woman Dies After Being Forced to Visit Bank Despite Critical Illness
President Trump Grants Full Pardons to Reality TV Stars Todd and Julie Chrisley
Texas Enacts App Store Accountability Act Mandating Age Verification
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Vatican Calls for Sustainable Tourism in 2025 Message
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
Trump Threatens 25% Tariff on iPhones Amid Dispute with Apple CEO
Putin's Helicopter Reportedly Targeted by Ukrainian Drones
Liverpool Car Ramming Incident Leaves Multiple Injured
Australia Faces Immigration Debate Following Labor Party Victory
Iranian Revolutionary Guard Founder Warns Against Trusting Regime in Nuclear Talks
Macron Dismisses Viral Video of Wife's Gesture as Playful Banter
Cleveland Clinic Study Questions Effectiveness of Recent Flu Vaccine
Netanyahu Accuses Starmer of Siding with Hamas
Junior Doctors Threaten Strike Over 4% Pay Offer
×